Epidemiology of Parkinson’s disease
The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cardiovascular dysautonomia in de novo Parkinson's disease
Oka, H., Mochio, S., Onouchi, K., Morita, M., Yoshioka, M., & Inoue, K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.014 · Cited by 69
RetractedParkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Recently, Braak and coworkers proposed a staging procedure of PD pathology from stage 1 to 6 [19, 20].”
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“During the last decade, several gene loci were found to be associated with autosomal-dominantly [45, 89, 121, 173] or recessively [81, 163, 165] inherited parkinsonism.”
BackgroundMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Hypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804 · cited 2×
“It is now clear that several brainstem nuclei and their communicating pathways in the ascending arousing system through the hypothalamus and thalamus to the cortex play key roles in sleep disorders [98, 136].”
BackgroundCloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,454
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
Self-citationWhat contributes to quality of life in patients with Parkinson's disease?
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,380
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313 · cited 2×
“In a community-based study, only 53 % of patients on antiparkinsonian drugs initiated by general practitioners due to suspected PD fulfilled UKBB criteria of probable PD when investigated by neurologists [104].”
MethodFatigue in neurological disorders
Chaudhuri, A., & Behan, P. O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15794-2 · Cited by 1,297
Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort
Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., et al. (1990) · Neurology · doi:10.1212/wnl.40.10.1529 · Cited by 1,285
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,251
A systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Restless Legs Syndrome Prevalence and Impact: REST General Population Study
Allen, R. P., Walters, A. S., Montplaisir, J., Hening, W., Myers, A., Bell, T. J., & Ferini-Strambi, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1286 · Cited by 1,182
Apathy: a neuropsychiatric syndrome
(1991) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.3.3.243 · Cited by 1,087
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050 · cited 3×
“In a prospective long-term study, 81 % of patients had fallen due to the disease after 15 years of follow-up [60].”
BackgroundInfluentialHallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 956
Montplaisir, J., Boucher, S., Poirier, G., Lavigne, G., Lapierre, O., & Lespérance, P. (1997) · Movement Disorders · doi:10.1002/mds.870120111 · Cited by 937
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Cognitive deficits in Parkinson’s disease
Dubois, B., & Pillon, B. (1996) · Journal of Neurology · doi:10.1007/pl00007725 · Cited by 903
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811 · cited 1×
“Hallucinations are one of the main features causing hospitalization and nursing home placement in patients with PD [181].”
BackgroundSelf-citationImproved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa
Djahanguiri, B., Hemmati, S., Sadeghi, D., & Firouzabadi, A. (1967) · Pharmacology · doi:10.1159/000137111 · Cited by 783
Association of olfactory dysfunction with risk for future Parkinson's disease
Ross, G. W., Petrovitch, H., Abbott, R. D., Tanner, C. M., Popper, J., Masaki, K., Launer, L., & White, L. R. (2008) · Annals of Neurology · doi:10.1002/ana.21291 · Cited by 742
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
Ponsen, M. M., Stoffers, D., Booij, J., van Eck‐Smit, B. L. F., Wolters, E. C., & Berendse, H. W. (2004) · Annals of Neurology · doi:10.1002/ana.20160 · Cited by 740
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721 · cited 1×
“The risk for developing dementia is up to 6-fold higher in PD than in non-PD subjects [176], and about 10 % of patients with PD develop dementia per year [99, 176].”
BackgroundSelf-citationThe cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., Paulsen, J. S., & Litvan, I. (1998) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.10.3.314 · Cited by 678
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
Ramaker, C., Marinus, J., Stiggelbout, A. M., & van Hilten, B. J. (2002) · Movement Disorders · doi:10.1002/mds.10248 · Cited by 666
Prevalence and risk factors of RLS in an elderly population: The MEMO Study
Rothdach, A. J., Trenkwalder, C., Haberstock, J., Keil, U., & Berger, K. (2000) · Neurology · doi:10.1212/wnl.54.5.1064 · Cited by 657
Mesholam, R. I., Moberg, P. J., Mahr, R. N., & Doty, R. L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.84 · Cited by 643
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642 · cited 1×
“In patients with more advanced disease, cross-sectional studies found prevalence rates between 40 % and 56 %, and the frequency of fatigue was found to be even higher (75 %) during off-state [172].”
BackgroundThe Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 638
McKeith, I. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s347 · Cited by 625
Prevalence and incidence of Parkinson's disease in Europe
von Campenhausen, S., Bornschein, B., Wick, R., Bötzel, K., Sampaio, C., Poewe, W., Oertel, W., Siebert, U., Berger, K., & Dodel, R. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.007 · Cited by 625
Systematic review of incidence studies of Parkinson's disease
Twelves, D., Perkins, K. S. M., & Counsell, C. (2003) · Movement Disorders · doi:10.1002/mds.10305 · Cited by 622
Boeve, B. F., Silber, M. H., Ferman, T. J., Lucas, J. A., & Parisi, J. E. (2001) · Movement Disorders · doi:10.1002/mds.1120 · Cited by 599
REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease
Gagnon, J. F., Bédard, M. A., Fantini, M. L., Petit, D., Panisset, M., Rompré, S., Carrier, J., & Montplaisir, J. (2002) · Neurology · doi:10.1212/wnl.59.4.585 · Cited by 598
A meta‐analysis of six prospective studies of falling in Parkinson's disease
Pickering, R. M., Grimbergen, Y. A. M., Rigney, U., Ashburn, A., Mazibrada, G., Wood, B., Gray, P., Kerr, G., & Bloem, B. R. (2007) · Movement Disorders · doi:10.1002/mds.21598 · Cited by 585
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland, D., Larsen, J. P., Lim, N. G., Janvin, C., Karlsen, K., Tandberg, E., & Cummings, J. L. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.492 · Cited by 581
Self-citationCognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Jansen Steur, E. N. H., Del Tredici, K., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 560
Freezing of gait in PD: Prospective assessment in the DATATOP cohort
Giladi, N., McDermott, M. P., Fahn, S., Przedborski, S., Jankovic, J., Stern, M., Tanner, C., & The Parkinson Study Group (2001) · Neurology · doi:10.1212/wnl.56.12.1712 · Cited by 545
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528 · cited 1×
“Provisional diagnostic criteria for PDPsy have recently been published [130].”
BackgroundValente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Pluck, G. C. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.636 · Cited by 473
Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study
Shiba, M., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<669::aid-mds1011>3.0.co;2-5 · Cited by 465
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Identification of Wake-Active Dopaminergic Neurons in the Ventral Periaqueductal Gray Matter
Lu, J., Jhou, T. C., & Saper, C. B. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2244-05.2006 · Cited by 458
Dementia and survival in Parkinson disease: A 12-year population study
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451 · cited 1×
“The cumulative incidence of dementia steadily increases with age and duration of PD and, conditional on survival, increases to 80 % to 90 % by age 90 years [22].”
BackgroundSelf-citationA community‐based study of sleep disorders in patients with Parkinson's disease
Tandberg, E., Larsen, J. P., & Karlsen, K. (1998) · Movement Disorders · doi:10.1002/mds.870130606 · Cited by 450
Self-citationThe pathogenesis of cell death in Parkinson's disease
Jenner, P., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 446
Herlofson, K., & Larsen, J. P. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.02033.x · Cited by 441
Self-citationPrevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437 · cited 4×
“Prospective studies indicate that advanced age rather than higher age at onset is a risk factor for PDD [72, 90, 175, 178].”
BackgroundInfluentialBurn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Self-citationComorbidity of the nonmotor symptoms of Parkinson's disease
Shulman, L. M., Taback, R. L., Bean, J., & Weiner, W. J. (2001) · Movement Disorders · doi:10.1002/mds.1099 · Cited by 417
The Occurrence of Depression in Parkinson's Disease: A Community-Based Study
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 409
Falls in frequent neurological diseases
Stolze, H., Klebe, S., Zechlin, C., Baecker, C., Friege, L., & Deuschl, G. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0276-8 · Cited by 382
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism
Boeve, B. F., Silber, M. H., Parisi, J. E., Dickson, D. W., Ferman, T. J., Benarroch, E. E., Schmeichel, A. M., Smith, G. E., Petersen, R. C., Ahlskog, J. E., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000073619.94467.b0 · Cited by 379
PARK7, a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, on Chromosome 1p36
van Duijn, C. M., Dekker, M. C. J., Bonifati, V., Galjaard, R. J., Houwing-Duistermaat, J. J., Snijders, P. J. L. M., Testers, L., Breedveld, G. J., Horstink, M., Sandkuijl, L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/322996 · Cited by 379
Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease
Comella, C. L., Nardine, T. M., Diederich, N. J., & Stebbins, G. T. (1998) · Neurology · doi:10.1212/wnl.51.2.526 · Cited by 374
A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease
Hughes, T. A., Ross, H. F., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H. S., & Spokes, E. G. S. (2000) · Neurology · doi:10.1212/wnl.54.8.1596 · Cited by 372
Exploring the Relationship Between Parkinson Disease and Restless Legs Syndrome
Ondo, W. G., Vuong, K. D., & Jankovic, J. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.421 · Cited by 367
An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996) · Brain · doi:10.1093/brain/119.2.585 · Cited by 366
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 348
Self-citationProspective study of hallucinations and delusions in Parkinson's disease
Holroyd, S. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.734 · Cited by 345
Higher incidence of depression preceding the onset of Parkinson's disease: A register study
Leentjens, A. F. G., Van den Akker, M., Metsemakers, J. F. M., Lousberg, R., & Verhey, F. R. J. (2003) · Movement Disorders · doi:10.1002/mds.10387 · Cited by 340
Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorders
Coleman Phd, R. M., Pollak, C. P., & Weitzman, E. D. (1980) · Annals of Neurology · doi:10.1002/ana.410080413 · Cited by 340
Olfactory loss may be a first sign of idiopathic Parkinson's disease
Haehner, A., Hummel, T., Hummel, C., Sommer, U., Junghanns, S., & Reichmann, H. (2007) · Movement Disorders · doi:10.1002/mds.21413 · Cited by 333
Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.
Doty, R. L., Stern, M. B., Pfeiffer, C., Gollomp, S. M., & Hurtig, H. I. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.2.138 · Cited by 328
Epidemiology of restless legs syndrome in French adults: A nationwide survey: The INSTANT Study
Tison, F., Crochard, A., Léger, D., Bouée, S., Lainey, E., & El Hasnaoui, A. (2005) · Neurology · doi:10.1212/01.wnl.0000168910.48309.4a · Cited by 323
Karlsen, K. H., Larsen, J. P., Tandberg, E., & Maland, J. G. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.4.431 · Cited by 321
Self-citationHow valid is the clinical diagnosis of Parkinson's disease in the community?
Schrag, A. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.529 · Cited by 300
The association of incident dementia with mortality in PD
Levy, G., Tang, M.-X., Louis, E. D., Côté, L. J., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Neurology · doi:10.1212/01.wnl.0000036610.36834.e0 · Cited by 297
Hilker, R., Schweitzer, K., Coburger, S., Ghaemi, M., Weisenbach, S., Jacobs, A. H., Rudolf, J., Herholz, K., & Heiss, W.-D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.378 · Cited by 293
Patient-reported autonomic symptoms in Parkinson disease
Verbaan, D., Marinus, J., Visser, M., van Rooden, S. M., Stiggelbout, A. M., & van Hilten, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000266593.50534.e8 · Cited by 283
The Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel-Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 283
Self-citationSuchowersky, O., Reich, S., Perlmutter, J., Zesiewicz, T., Gronseth, G., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215437.80053.d0 · Cited by 280
Progression of motor impairment and disability in Parkinson disease: A population-based study
Alves, G., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. P. (2005) · Neurology · doi:10.1212/01.wnl.0000183359.50822.f2 · Cited by 271
Self-citationGrimbergen, Y. A., Munneke, M., & Bloem, B. R. (2004) · Current Opinion in Neurology · doi:10.1097/01.wco.0000137530.68867.93 · Cited by 268
Restless legs syndrome in an Asian population: A study in Singapore
Tan, E. K., Seah, A., See, S. J., Lim, E., Wong, M. C., & Koh, K. K. (2001) · Movement Disorders · doi:10.1002/mds.1102 · Cited by 268
The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease
Marder, K., Tang, M.-X., Cote, L., Stern, Y., & Mayeux, R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310069018 · Cited by 268
Accuracy of diagnosis in patients with presumed Parkinson's disease
Meara, J. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.99 · Cited by 265
Daytime sleepiness in Parkinson’s disease
Rye, D. B., Bliwise, D. L., Dihenia, B., & Gurecki, P. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00201.x · Cited by 260
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251
Molecular Pathogenesis of Parkinson Disease
Eriksen, J. L., Wszolek, Z., & Petrucelli, L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.353 · Cited by 248
Gjerstad, M. D., Boeve, B., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. P. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.116830 · Cited by 246
Self-citationSommer, U., Hummel, T., Cormann, K., Mueller, A., Frasnelli, J., Kropp, J., & Reichmann, H. (2004) · Movement Disorders · doi:10.1002/mds.20141 · Cited by 244
Exacerbated physical fatigue and mental fatigue in Parkinson's disease
Lou, J., Kearns, G., Oken, B., Sexton, G., & Nutt, J. (2001) · Movement Disorders · doi:10.1002/mds.1042 · Cited by 244
Heterogeneity in male to female risk for Parkinson's disease
Taylor, K. S. M., Cook, J. A., & Counsell, C. E. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104695 · Cited by 238
Effects of fatigue on physical activity and function in patients with Parkinson’s disease
Garber, C. E., & Friedman, J. H. (2003) · Neurology · doi:10.1212/01.wnl.0000055868.06222.ab · Cited by 232
Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
Findley, L., Aujla, M., Bain, P. G., Baker, M., Beech, C., Bowman, C., Holmes, J., Kingdom, W. K., MacMahon, D. G., Peto, V., et al. (2003) · Movement Disorders · doi:10.1002/mds.10507 · Cited by 227
Insomnia in Parkinson's disease: frequency and progression over time
Gjerstad, M. D., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. P. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100370 · Cited by 225
Self-citationMotor impairment in PD: Relationship to incident dementia and age
Levy, G., Tang, M.-X., Cote, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2000) · Neurology · doi:10.1212/wnl.55.4.539 · Cited by 225
Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
Scherfler, C., Schwarz, J., Antonini, A., Grosset, D., Valldeoriola, F., Marek, K., Oertel, W., Tolosa, E., Lees, A. J., & Poewe, W. (2007) · Movement Disorders · doi:10.1002/mds.21505 · Cited by 219
Is fatigue an independent and persistent symptom in patients with Parkinson disease?
Alves, G., Wentzel-Larsen, T., & Larsen, J. P. (2004) · Neurology · doi:10.1212/01.wnl.0000144277.06917.cc · Cited by 215 · cited 2×
“In more than half of patients, fatigue was a persistent feature when once experienced [9].”
BackgroundSelf-citationNeuropsychological Profile of Patients with Parkinson’s Disease without Dementia
Janvin, C., Aarsland, D., Larsen, J. P., & Hugdahl, K. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000068483 · Cited by 212
Self-citationClinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease
Isella, V., Melzi, P., Grimaldi, M., Iurlaro, S., Piolti, R., Ferrarese, C., Frattola, L., & Appollonio, I. (2002) · Movement Disorders · doi:10.1002/mds.10041 · Cited by 212
Progression of Parkinsonian Signs in Parkinson Disease
Louis, E. D., Tang, M. X., Cote, L., Alfaro, B., Mejia, H., & Marder, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.334 · Cited by 211
The pathogenesis of cell death in Parkinson's disease – 2007
Olanow, C. W. (2007) · Movement Disorders · doi:10.1002/mds.21675 · Cited by 211
Combined effect of age and severity on the risk of dementia in Parkinson's disease
Levy, G., Schupf, N., Tang, M., Cote, L. J., Louis, E. D., Mejia, H., Stern, Y., & Marder, K. (2002) · Annals of Neurology · doi:10.1002/ana.10219 · Cited by 209
Prognostic factors for the progression of Parkinson's disease: A systematic review
Post, B., Merkus, M. P., de Haan, R. J., Speelman, J. D., & CARPA Study Group (2007) · Movement Disorders · doi:10.1002/mds.21537 · Cited by 206
Garcia-Borreguero, D., Larrosa, O., & Bravo, M. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0229 · Cited by 204
Restless legs syndrome in Parkinson's disease: A case‐controlled study
Krishnan, P. R., Bhatia, M., & Behari, M. (2003) · Movement Disorders · doi:10.1002/mds.10307 · Cited by 203
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
Williams, D. R. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074070 · Cited by 203
Risk Factors for Depression in Parkinson Disease
Tandberg, E., Larsen, J. P., Aarsland, D., Laake, K., & Cummings, J. L. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170097020 · Cited by 202
Self-citationKoller, W. C., Hutton, J. T., Tolosa, E., Capilldeo, R., & the Carbidopa/Levodopa Study Group (1999) · Neurology · doi:10.1212/wnl.53.5.1012 · Cited by 200
Clinical features of LRRK2‐associated Parkinson's disease in central Norway
Aasly, J. O., Toft, M., Fernandez‐Mata, I., Kachergus, J., Hulihan, M., White, L. R., & Farrer, M. (2005) · Annals of Neurology · doi:10.1002/ana.20456 · Cited by 191
Occupational and environmental risk factors for Parkinson's disease
Lai, B. C. L., Marion, S. A., Teschke, K., & Tsui, J. K. C. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00054-2 · Cited by 188
Predicting Motor Decline and Disability in Parkinson Disease: A Systematic Review
Marras, C., Rochon, P., & Lang, A. E. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1724 · Cited by 187
Excessive daytime sleepiness in Parkinson disease: Is it the drugs or the disease?
Gjerstad, M. D., Alves, G., Wentzel-Larsen, T., Aarsland, D., & Larsen, J. P. (2006) · Neurology · doi:10.1212/01.wnl.0000233980.25978.9d · Cited by 186
Self-citationPost-Lyme borreliosis syndrome: a meta-analysis of reported symptoms
Cairns, V., & Godwin, J. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi129 · Cited by 184
Beyer, M. K., Herlofson, K., Årsland, D., & Larsen, J. P. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00191.x · Cited by 183 · cited 1×
“The cause of death in patients with PD are often related to immobility, and fatal infections are not unusual [12].”
BackgroundSelf-citationGender differences in Parkinson's disease
Shulman, L. M. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80003-9 · Cited by 183
Factors Associated With the Development of Motor Fluctuations and Dyskinesias in Parkinson Disease
Hauser, R. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1756 · Cited by 183
Nilsson, F. M., Kessing, L. V., & Bolwig, T. G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00372.x · Cited by 180
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179
Prospective longitudinal assessment of hallucinations in Parkinson’s disease
Goetz, C. G., Leurgans, S., Pappert, E. J., Raman, R., & Stemer, A. B. (2001) · Neurology · doi:10.1212/wnl.57.11.2078 · Cited by 178
Rate of clinical progression in Parkinson's disease. A prospective study
Schrag, A., Dodel, R., Spottke, A., Bornschein, B., Siebert, U., & Quinn, N. P. (2007) · Movement Disorders · doi:10.1002/mds.21429 · Cited by 171
Hallucinations in Parkinson disease in the prelevodopa era
Fénelon, G., Goetz, C. G., & Karenberg, A. (2006) · Neurology · doi:10.1212/01.wnl.0000191325.31068.c4 · Cited by 169
Epidemiologic studies of environmental exposures in Parkinson's disease
Elbaz, A., & Tranchant, C. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.024 · Cited by 167
The premotor phase of Parkinson's disease
Tolosa, E., Compta, Y., & Gaig, C. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.007 · Cited by 165
The effect of age of onset of PD on risk of dementia
Aarsland, D., Kvaløy, J. T., Andersen, K., Larsen, J. P., Tang, M. X., Lolk, A., Kragh-Sørensen, P., & Marder, K. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0234-8 · Cited by 162 · cited 4×
“However, as dementia is associated with increased mortality [92], cross-sectional studies are likely to underestimate the true frequency of PDD. Prospective follow-up of an Australian cohort revealed that 17 years after disease onset, only 15 % of surviving subjects were not cognitively impaired [60].”
BackgroundInfluentialSelf-citationEconomic burden and quality of life impairment increase with severity of PD
Keränen, T., Kaakkola, S., Sotaniemi, K., Laulumaa, V, Haapaniemi, T., Jolma, T., Kola, H., Ylikoski, A., Satomaa, O., Kovanen, J., et al. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00097-4 · Cited by 162
Cost of Illness and its Predictors for Parkinson??s Disease in Germany
Spottke, A. E., Reuter, M., Machat, O., Bornschein, B., von Campenhausen, S., Berger, K., Köhne-Volland, R., Rieke, J., Simonow, A., Brandstädter, D., et al. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523080-00007 · Cited by 162
Waking up to sleep episodes in Parkinson's Disease
Olanow, C. W., Schapira, A. H. V., & Roth, T. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2<212::aid-mds1002>3.0.co;2-6 · Cited by 160
Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050845 · Cited by 159
Muller, A. M., Reichmann, H., Livermore, A., & Hummel, T. R. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200067 · Cited by 159
How common are complications of Parkinson's disease?
Schrag, A. E., Ben‐Shlomo, Y., & Quinn, N. P. (2002) · Journal of Neurology · doi:10.1007/s004150200032 · Cited by 159
Development of daytime somnolence over time in Parkinson’s disease
Gjerstad, M. D., Aarsland, D., & Larsen, J. P. (2002) · Neurology · doi:10.1212/wnl.58.10.1544 · Cited by 156
Self-citationAllcock, L. M. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029413 · Cited by 155
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E.-K., Gaig, C., Tolosa, E., Goldwurm, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304044.22253.03 · Cited by 153
Nomura, T., Inoue, Y., Miyake, M., Yasui, K., & Nakashima, K. (2005) · Movement Disorders · doi:10.1002/mds.20734 · Cited by 151
Major depressive disorder in Parkinson's disease: a register‐based study
Nilsson, F. M., Kessing, L. V., Sørensen, T. M., Andersen, P. K., & Bolwig, T. G. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02229.x · Cited by 148
Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort
Marras, C., McDermott, M. P., Rochon, P. A., Tanner, C. M., Naglie, G., Rudolph, A., Lang, A. E., & the Parkinson Study Group (2005) · Neurology · doi:10.1212/01.wnl.0000148603.44618.19 · Cited by 143
Sleep issues in Parkinson’s disease
Adler, C. H., & Thorpy, M. J. (2005) · Neurology · doi:10.1212/wnl.64.12_suppl_3.s12 · Cited by 139
PERRY, E. K., MCKEITH, I., THOMPSON, P., MARSHALL, E., KERWIN, J., JABEEN, S., EDWARDSON, J. A., Ince, P., BLESSED, G., IRVING, D., et al. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00217.x · Cited by 138
Olfactory function distinguishes vascular parkinsonism from Parkinson's disease
Katzenschlager, R. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.035287 · Cited by 137
Epidemiology of Parkinsonʼs disease and akinetic syndromes
Tanner, C. M., & Aston, D. A. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00010 · Cited by 133
3-OMD and homocysteine plasma levels in parkinsonian patients.
Müller, T., Woitalla, D., Fowler, B., & Kuhn, W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200013 · Cited by 130
The natural history of parkinson's disease
Poewe, W. H., & Wenning, G. K. (1998) · Annals of Neurology · doi:10.1002/ana.410440703 · Cited by 129
Resource use and costs in a Swedish cohort of patients with Parkinson's disease
Hagell, P., Nordling, S., Reimer, J., Grabowski, M., & Persson, U. (2002) · Movement Disorders · doi:10.1002/mds.10262 · Cited by 123
The clinical features of Parkinson's disease in 100 histologically proven cases.
Aj, H., Daniel, S. E., & Lees, A. J. (1993) · PubMed · Cited by 121
Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study
Müller, J., Wenning, G. K., Jellinger, K., McKee, A., Poewe, W., & Litvan, I. (2000) · Neurology · doi:10.1212/wnl.55.6.888 · Cited by 120
Horn, G. V., Schiess, M. C., & Koller, W. C. (2000) · Neurology · doi:10.1212/wnl.55.1.156 · Cited by 119
Hallucinations in Parkinson's disease: A follow‐up study
Doé de Maindreville, A., Fénelon, G., & Mahieux, F. (2005) · Movement Disorders · doi:10.1002/mds.20263 · Cited by 118
Are Patients with Parkinson's Disease Suicidal?
Myslobodsky, M., Lalonde, F. M., & Hicks, L. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400304 · Cited by 115
Snoring and excessive daytime sleepiness in Parkinson's disease
Braga‐Neto, P., da Silva‐Júnior, F. P., Monte, F. S., de Bruin, P. F. C., & de Bruin, V. M. S. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.08.010 · Cited by 114
Bauer, J. (1950) · Europe PMC (PubMed Central) · Cited by 111
Seppi, K., & Schocke, M. F. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000173141.74137.63 · Cited by 108
Fénelon, G. (2008) · CNS Spectrums · doi:10.1017/s1092852900017284 · Cited by 106
Uitti, R. J., Baba, Y., Wszołek, Z. K., & Putzke, D. J. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.007 · Cited by 104
Cigarette smoking in Parkinson's disease: Influence on disease progression
Alves, G. W., Kurz, M. W., Lie, S. A., & Larsen, J. O. (2004) · Movement Disorders · doi:10.1002/mds.20117 · Cited by 104
Self-citationOrthostatic hypotension in de novo Parkinson disease
Bonuccelli, U., Lucetti, C., Del Dotto, P., Ceravolo, R., Gambaccini, G., Bernardini, S., Rossi, G., & Piaggesi, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1400 · Cited by 103
Case–control study of restless legs syndrome and quality of sleep in Parkinson's disease
Loo, H.-V., & Tan, E. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.09.033 · Cited by 97
Motor complications in Parkinson disease: Clinical manifestations and management
Bhidayasiri, R., & Truong, D. D. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.028 · Cited by 93
Bronnick, K., Emre, M., Lane, R., Tekin, S., & Aarsland, D. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108076 · Cited by 89
Age at onset: the major determinant of outcome in Parkinson's disease
Hely, M. A., Morris, J. G. L., Reid, W. G. J., O'Sullivan, D. J., Williamson, P. M., Broe, G. A., & Adena, M. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb00480.x · Cited by 88
Mortality and Parkinson disease: A community based study
Herlofson, K., Lie, S. A., Årsland, D., & Larsen, J. P. (2004) · Neurology · doi:10.1212/01.wnl.0000115116.56955.50 · Cited by 82
Self-citationRisk factors for progression in Parkinson's disease
Goetz, C. G., Tanner, C. M., Stebbins, G. T., & Buchman, A. S. (1988) · Neurology · doi:10.1212/wnl.38.12.1841 · Cited by 78
Suicide in patients with Parkinson's disease: An epidemiological study
Stenager, E. N., Wermuth, L., Stenager, E., & Boldsen, J. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01558.x · Cited by 74
Abnormal co-contraction in yips-affected but not unaffected golfers: Evidence for focal dystonia
Adler, C. H., Crews, D., Hentz, J. G., Smith, A. M., & Caviness, J. N. (2005) · Neurology · doi:10.1212/01.wnl.0000162024.05514.03 · Cited by 72
Morrish, P. (2003) · Movement Disorders · doi:10.1002/mds.10581 · Cited by 69
Chronic fatigue in developing countries: population based survey of women in India
Patel, V., Kirkwood, B. R., Weiss, H., Pednekar, S., Fernandes, J., Pereira, B., Upadhye, M., & Mabey, D. (2005) · BMJ · doi:10.1136/bmj.38442.636181.e0 · Cited by 68
Parkinson's disease risk factors: genetic, environmental, or both?
Allam, M. F., del Castillo, A. S., & Navajas, R. F. (2005) · Neurological Research · doi:10.1179/016164105x22057 · Cited by 58
Kandinov, B., Giladi, N., & Korczyn, A. D. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.11.004 · Cited by 51
Familial aggregation of Parkinson's disease in a Finnish population
Autere, J. M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.107 · Cited by 49
Determinants of autonomic dysfunction in idiopathic Parkinson’s disease
Korchounov, A., Kessler, K. R., Yakhno, N. N., Damulin, I. V., & Schipper, H. I. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0909-6 · Cited by 43
Clinical problems in non-fluctuating patients with Parkinson's disease: A community-based study
Larsen, J. O., Karlsen, K., & Tandberg, E. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<826::aid-mds1010>3.0.co;2-e · Cited by 43
Self-citationFamilial Parkinson's disease: a community‐based study
Kurz, M. W., Alves, G. W., Aarsland, D., & Larsen, J. O. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00532.x · Cited by 36
Self-citationDementia in Parkinson’s Disease
Pfeiffer, R. F., Wszolek, Z. K., & Ebadi, M. (2004) · CRC Press eBooks · doi:10.1201/9780203508596-43 · Cited by 32
Dementia in Parkinson's disease.
Rippon, G. A., & Marder, K. S. (2005) · PubMed · Cited by 32
Restless Legs Syndrome and Parkinson’s Disease: Is there an etiologic link?
Tan, E. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7008-1 · Cited by 29
Motor Complications in Parkinson Disease:
Ruiz, P., Meseguer, E., del Val, J., Vazquez, A., Bernardos, V. S., & Vázquez, A. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00001 · Cited by 26
Litvan, I. (1998) · JAMA · doi:10.1001/jama.280.19.1654 · Cited by 22
Meara, J., Bhowmick, B. K., & Hobson, P. (1997) · Age and Ageing · doi:10.1093/ageing/26.suppl_3.p14-a · Cited by 20
Cited by
The epidemiology of Parkinson's disease
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., & Tanner, C. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01419-8 · Cited by 967
Olfaction in Parkinson's disease and related disorders
Doty, R. L. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.026 · Cited by 431
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Parkinson’s disease: The non-motor issues
Chaudhuri, K. R., Odin, P., Antonini, A., & Martinez-Martin, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.018 · Cited by 388
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
Videnovic, A., Lazar, A. S., Barker, R. A., & Overeem, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.206 · Cited by 373
Metadata
- Authors
- Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz Gjerstad, M., & Larsen, J. P.
- Venue
- Journal of Neurology
- Published
- 2008-09
- Volume
- 255
- Issue
- S5
- Pages
- 18-32
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2077560786
- Cited by
- 363
- References
- 186
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.